ReviewFrontiers in cell and developmental biology2021

Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases.

Matthew Luzentales-Simpson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.